KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Cash & Current Investments (2019 - 2025)

Historic Cash & Current Investments for GoodRx Holdings (GDRX) over the last 7 years, with Q3 2025 value amounting to $273.5 million.

  • GoodRx Holdings' Cash & Current Investments fell 3545.45% to $273.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $273.5 million, marking a year-over-year decrease of 3545.45%. This contributed to the annual value of $448.3 million for FY2024, which is 3331.12% down from last year.
  • Per GoodRx Holdings' latest filing, its Cash & Current Investments stood at $273.5 million for Q3 2025, which was down 3545.45% from $281.3 million recorded in Q2 2025.
  • GoodRx Holdings' Cash & Current Investments' 5-year high stood at $993.4 million during Q1 2021, with a 5-year trough of $273.5 million in Q3 2025.
  • In the last 5 years, GoodRx Holdings' Cash & Current Investments had a median value of $730.5 million in 2022 and averaged $662.1 million.
  • In the last 5 years, GoodRx Holdings' Cash & Current Investments surged by 93651.3% in 2021 and then crashed by 4668.83% in 2024.
  • Over the past 5 years, GoodRx Holdings' Cash & Current Investments (Quarter) stood at $941.1 million in 2021, then decreased by 19.55% to $757.2 million in 2022, then fell by 11.21% to $672.3 million in 2023, then plummeted by 33.31% to $448.3 million in 2024, then crashed by 38.99% to $273.5 million in 2025.
  • Its Cash & Current Investments was $273.5 million in Q3 2025, compared to $281.3 million in Q2 2025 and $301.0 million in Q1 2025.